The US may open a trade investigation into Switzerland's pharmaceutical industry, threatening tariffs on $35.5 billion in imports and pressuring Roche and

The US may open a trade investigation into Switzerland's pharmaceutical industry, threatening tariffs on $35.5 billion in imports and pressuring Roche and

Interpharma warns Switzerland may face a US Section 301 trade probe targeting drug pricing, threatening $35.5 billion in pharma exports from Roche and